IBIO vs ACHV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 13, 2026

IBIO

42.7
AI Score
VS
IBIO Wins

ACHV

31.9
AI Score

Investment Advisor Scores

IBIO

43score
Recommendation
HOLD

ACHV

32score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric IBIO ACHV Winner
Net Income -32.84M -16.39M ACHV
ROE -38.3% -90.8% IBIO
ROA -33.1% -77.8% IBIO
Total Assets 99.11M 21.08M IBIO
Cash 56.40M 16.66M IBIO
Current Ratio 7.85 6.04 IBIO
Free Cash Flow -23.80M -15.27M ACHV

Relative Price Performance (Last 90 Days)

IBIO 1M: -18.0% · 3M: -27.8% ACHV 1M: +5.5% · 3M: +27.9%

Current Technical Phase

IBIO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -8.8%), weak momentum, RSI 31

RSI (14): 30.5 · Price: $1.21

ACHV

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 42

RSI (14): 41.7 · Price: $7.06

Fundamentals Snapshot

Metric IBIO ACHV
Market Cap
Forward P/E -3.9 -11.1
Trailing P/E
Revenue (TTM)
Revenue Growth -1.0% 0.0%
Gross Margin 1.0%
Operating Margin -301.4% 0.0%
EPS -0.31 -1.66
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, IBIO is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.